Survival benefit with erlotinib maintenance therapy in patients with advanced non-small-cell lung cancer (NSCLC) according to response to first-line chemotherapy
収録刊行物
-
- Annals of Oncology
-
Annals of Oncology 23 (2), 388-394, 2012-02
Elsevier BV